Andersson et al. bioRxiv 2020 (preprint) |
Lundeberg |
Human |
Cancer |
8x HER2 + breast tumours |
Both |
Cells spatially selected from fixed tissue sections |
Spatial transcriptomics developed by Ståhl et al. Science 2016 |
1007 spots (where spot refers to a small neighbourhood populated by multiple cells) |
Azizi et al. Cell 2018 |
Pe’er and Rudensky |
Human |
Both |
8x primary breast carcinomas tumour and matched normal breast tissue, peripheral blood and lymph nodes |
Stroma-imune |
CD45+ FACS sorted cells |
scRNA-seq using the inDrop platform |
47,016 cells |
Bach et al. Nature Comm 2017 |
Marioni and Khaled |
Mouse |
Normal |
Mammary cells taken during pregnancy (day 14.5), lactation (day 6), involution (day 11) and from virgin 8 week old C57BL/6N mice |
Epithelial |
Live lineage negative EpCAM+ cells sorted using FACS |
scRNA-seq using Chromium 10x Drop-Seq platform |
23,184 cells |
Bach and Pensa et al. Nature Comm 2021 |
Khaled and Marioni |
Mouse |
Both |
Tumourogenesis data set: 13 x Blg-Cre; Brca1f/f;p53 + /- mice (aged 30–48 weeks, nulliparous) and 2x C57BL/6N mice (aged 36–40 weeks old) |
Both |
Viable cells were isolated using MACS Dead Cell Removal Kit |
scRNA-seq using Chromium 10x Drop-Seq platform |
102,829 cells |
Pregnancy data set: 9x C57BL/6N mice at 4.5/9.5/14.5 days gestation as well as 3x C57BL/6N mice (aged 12 weeks old) |
Bartoschek et al. Nature Comm 2018 |
Pietras |
Mouse |
Cancer |
Tumours from 14 week old MMTV-PyMT mice |
Stroma-imune |
EpCAM-/CD45-/CD31-/NG2- FACS sorted mesenchymal cells |
scRNA-seq using Smart-Seq2 |
768 cells |
Baslan et al. eLife 2020 |
Hicks |
Human |
Cancer |
Fresh pre-treatment core biopsies were taken from 16 patients’ enroled in phase II clinical trials conducted by the Brown University Oncology Group (BrUOG) |
Both |
Nuclei was isolated and FACS sorted for ploidy |
Single-nuclei copy number analysis developed by Baslan et al. Nature Protocols 2012 |
Mean of 116 single-nuclei per tumour |
Carli et al. J Mammary Gland Biol Neoplasia 2020 |
Rudolph |
Human |
Normal |
Human milk cells from two participants |
Both |
Viable cells were isolated using FACS |
scRNA-seq using Chromium 10x Drop-Seq platform |
3740 cells |
Casasent et al. Cell 2018 |
Edgerton and Navin |
Human |
Cancer |
10x ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) tumour samples |
Both |
Cells selected using single cell laser dissection |
Topographic single cell sequencing (TSCS, scDNA sequencing) |
On average 129 cells per patient |
Chung et al. Nature Comm 2017 |
Park |
Human |
Cancer |
11x tumour cells from different breast cancer subtypes |
Both |
Dead cells were removed using Ficoll-Paque PLUS |
scATAC-seq using the Fluidigm C1 platform |
515 cells |
Chung et al. Cell Reports 2019 |
Wahl |
Mouse |
Normal |
Mammary cells from E18 foetal and 8-week old adult CD1 mice |
Epithelial |
EpCAM+/Lin- FACS sorted cells |
snATAC-seq |
7846 high quality single nuclei |
Engelbrecht and Twigger et al. bioRxiv 2020 (preprint) |
Scheel and Khaled |
Human |
Normal |
Mammary tissue from one participant was digested 3 ways (3 h vs. 16 h digest and 10 rpm vs. 100 rpm. shaking speed). |
Both |
Viable cells were isolated using MACS Dead Cell Removal Kit |
scRNA-seq using Chromium 10x Drop-Seq |
11,191 cells |
Gao et al. Nature Comm 2017 |
Navin |
Human |
Cancer |
Breast cancer cell lines for technique validation and a single triple negative breast tumour sample |
Both |
Nuclei isolated from frozen tumour and cell lines |
Nanogrid snRNA-seq
|
796 primary cell nuclei |
Giraddi et al. Cell Rep 2019 |
Wahl and Spike |
Mouse |
Normal |
Mammary cells isolated from day 16/18 embryonic (E16, E18), postnatal day 10 (P10) and 10–16-week-old adult C57BL/6 mice |
Epithelial |
EpCAM+ FACS sorted cells |
scRNA-seq using Chromium 10x Drop-Seq and Fluidigm C1 platforms |
6060 cells using 10x and 262 cells using Fluidigm C1 |
Gkountela et al. Cell 2019 |
Aceto |
Human |
Cancer |
Blood samples containing circulating tumour cells (CTCs) from 43 patients with progressive breast cancer |
Both |
Live CTSs were stained for EpCAM, HER2 and EGFR and sorted for CTCs |
Single Cell Whole-genome Bisulfite Sequencing developed by Farlik et al. Cell Rep. 2015 |
89 single CTCs and 71 CTC clusters from patients and xenographs |
Grosselin et al. Nature Genetics 2019 |
Griffiths, Vallot and Gérard |
Mouse and Human |
Cancer |
Patient derived xenogrft mouse models of luminal and treatment resistant breast cancers |
Both |
Viable cells were isolated using MACS Dead Cell Removal Kit |
scChIP-seq and scRNA-seq |
2728 cells profiled by scRNA-seq |
Han et al. Cell 2018 |
Guo |
Mouse |
Normal |
Mammary cells taken during pregnancy, lactation, involution and from virgin C57BL/6 mice |
Both* |
Cells from all major mice organs including mammary gland. *However, no mention was made of removal of the mammary lymph nodes prior to mammary gland dissociation. |
scRNA-seq using microwell-seq |
61,196 mammary gland cells |
Kanaya et al. Commun Biol 2019 |
Chen |
Mouse |
Normal |
Mammary cells from 9-week-old BALB/cj mice which underwent ovariectomy (surgical menopause) and were treated with vehicle, E2 and/or PBDE |
Both |
Dead cells were removed using microbeads |
scRNA-seq using Chromium 10x Drop-Seq platform |
14,856 cells |
Karaayvaz et al. Nature Comm 2018 |
Ellisen |
Human |
Cancer |
6x primary triple negative breast tumours |
Both |
Viable tumour cells were isolated by FACS sorting |
scRNA-seq using Smart-seq2 |
1189 cells |
Knapp et al. Cell Reports 2017 |
Eaves |
Human |
Both |
7x breast cancer cell lines and 8x normal primary breast tissue samples |
Both |
N/A |
Mass cytometry using 35 markers (16 extracellular and 19 intracellular) |
Not disclosed |
Li et al. Cell Reports 2020 |
Brugge |
Mouse |
Normal |
Mammary cells from young (3–4 month, n = 3) and aged (13–14 month, n = 4) old virgin C57BL/6 J mice |
Both |
None |
scRNA-seq using Chromium 10x Drop-Seq platform |
13,684 cells |
Lo et al. Cancers 2020 |
Zhou |
Mouse |
Normal |
Mammary cells were isolated from normal and high fat diet (HFD) fed 2 month old C57BL/6 Brca1-/-;p53+/- mice |
Stroma-imune |
EpCAM- FACs sorted viable stromal and immune cells |
scRNA-seq using Chromium 10x Drop-Seq platform |
3892 cells |
Murrow et al. bioRxiv 2020 (preprint v4) |
Gartner |
Human |
Normal |
Mammary cells isolated from 28x premenopausal women of varying BMI and age |
Both |
Live (DAPI-) cells were sorted using CD31-/CD45-/EpCAM+/-/ CD49f+/- and CD45+
|
scRNA-seq using Chromium 10x Drop-Seq platform |
87,793 cells |
Nguyen et al. Nature Comms 2018 |
Kessenbrock |
Human |
Normal |
Mammary cells isolated from 7x individuals whom underwent reduction mammoplasties |
Epithelial |
CD31-/CD45- epithelial cells enriched by FACs sorting using CD49f and EpCAM |
scRNA-seq using Chromium 10x Drop-Seq and Fluidigm C1 platforms |
24,646 cells using 10x and 868 cells using Fluidigm C1 |
Pal et al. Nature Comms 2017 |
Visvader |
Mouse |
Normal |
Mammary cells were isolated from early postnatal (2 week old), mid-pubertal (5 weeks old) and mature adult (10 weeks, either from virgin or pregnant) FVB/NJ mice |
Epithelial |
CD45-/CD31-/CD24+ epithelial cells were FACS enriched |
scRNA-seq using Chromium 10x Drop-Seq and Fluidigm C1 platforms |
3308 cells using 10x and 460 cells using Fluidigm C1 |
Pervolarakis et al. Cell Reports 2020 |
Watanabe and Kessenbrock |
Mouse |
Normal |
Mammary cells were isolated from 10-week-old FVB/NJ mice |
Both |
FACS sorting using markers CD31, CD45, EpCAM and CD49f separated live cells for scRNA-seq and basal/luminal cells for scATAC-seq |
scRNA-seq and scATAC-seq was performed using 10x Genomics Chromium platforms |
26,859 cells were profiled using scRNA-seq and 23,338 cells were profiled using scATAC-seq |
Salmén et al. bioRxiv 2018 (preprint) |
Lundeberg |
Human |
Cancer |
Tumour tissue sections from 10 patients diagnosed with HER2 + breast cancer |
Both |
N/A |
Spatial Transcriptomics developed by Ståhl et al. Science 2016 and others |
1007 spatial spots |
Sebastian et al. Cancers 2020 |
Loots |
Mouse |
Cancer |
Mammary cells were extracted from 10-week-old BALB/c mice with 4T1 derived mammary tumours (a synergistic model for triple negative breast cancer) |
Stroma |
Using magnetic cell separation, CD45 depleted or CD45/CD90.1 depleted cells were sequenced, as well as bulk cells and CD140a+/EpCAM-/CD45-/7AAD- FACS sorted fibroblasts. |
scRNA-seq using Chromium 10x Drop-Seq platform |
6420 cells |
Sun et al. J. Biol. Chem. 2018 |
Deng |
Mouse |
Normal |
Mammary cells were isolated from 3 to 4 month-old virgin or day 12.5 pregnant FVB mice |
Epithelial |
Lineage positive (Lin+, endothelial or immune) cells were excluded using the EasySeq mouse epithelial cell enrichment kit. Luminal and basal cells were FACS sorted for using CD24 and CD29 |
scRNA-seq using Fluidigm C1 platform |
239 cells |
Thong et al. Front. Cell Dev. Biol. 2020 |
Colacino |
Human |
Normal |
Mammary cells were isolated from 3x normal mammoplasty tissue samples. Additionally, mammary cells from the 3 patients were conditionally reprogrammed in vitro and also sequenced. |
Both |
None |
scRNA-seq using drop-seq protocols developed by Macosko et al. 2015. |
Not disclosed |
The Tabula Muris Consortium Nature 2020 |
– |
Mouse |
Normal |
Mammary cells taken from at 3, 18 and 21 months from C57BL/6JN mice |
Both* |
Cells from all major mice organs including mammary gland. *However, no mention was made of removal of the mammary lymph nodes prior to mammary gland dissociation. |
scRNA-seq using Chromium 10x Drop-Seq platform |
15,577 mammary cells |
Tognetti et al. bioRxiv 2020 (preprint) |
Bodenmiller |
Human cell lines |
Both |
62x breast cancer cell lines and 5x normal cell lines |
N/A |
N/A |
Mass cytometry using 34 markers |
> 80 million cells |
Twigger et al. bioRxiv 2020 (preprint) |
Khaled and Scheel |
Human |
Normal |
4x samples from participants donating mammoplasty tissue and 4x human milk samples from lactating women |
Both |
None |
scRNA-seq using Chromium 10x Drop-Seq platform |
24,666 non-lactating breast cells and 27,023 human milk cells |
Vatter et al., Cell Reports 2018 |
Bodenmiller, LaBarge and Lorens |
Human |
Normal |
57 samples were profiled consisting of cultured cells from 44 women and 13 uncultured breast epithelia samples. |
Epithelia |
N/A |
Mass cytometry using 29 markers |
880,000 cells |
Wagner at al. Cell 2019 |
Bodenmiller |
Human |
Both |
144x human breast tumours and 50x normal breast tissue samples |
Both |
N/A |
Mass cytometry using 73 markers |
26 million cells |
Wang et al. eLife 2020 |
Schwertfeger |
Mouse |
Normal |
Mammary cells isolated from 10-week-old dioestrus FVB/NJ mice |
Stroma-imune |
CD45+ cells were enriched for using magnetic cell separation |
scRNA-seq using Chromium 10x Drop-Seq platform |
13,000 cells were targeted |
Wu et al. EMBO J 2020 |
Swarbrick |
Human |
Cancer |
5x triple negative breast tumours |
Both |
Viable cells were enriched for using EasySep Dead Cell Removal Kit |
scRNA-seq using Chromium 10x Drop-Seq platform |
24,271 cells |
Wuidart et al. Nat Cell Biol 2018 |
Blanpain |
Mouse |
Normal |
Mammary cells were isolated from embryonic day 14 (E14) and > 8-week-old adult mice |
Epithelial |
Embryonic CD49fHi/Lgr5Hi cells, adult CD24+/CD29Hi basal and adult CD24+/CD29Lo luminal cells were FACS enriched |
scRNA-seq using Smart-seq2 |
193 cells |